+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid prevents cholesterol crystallization in human gallbladder bile by increasing and stabilizing the lamellar carrier



Ursodeoxycholic acid prevents cholesterol crystallization in human gallbladder bile by increasing and stabilizing the lamellar carrier



Hepatology 16(4 Part 2): 154A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144882

Download citation: RISBibTeXText


Related references

Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae. Journal of Hepatology 22(6): 642-657, 1995

Pronucleating proteins in gallbladder bile Relation to stone type, number, speed of cholesterol crystallization and ursodeoxycholic acid therapy. Gastroenterology 110(4 Suppl. ): A1351, 1996

Lamellar stacks coexist with vesicles and micelles in human gallbladder bile and prevent cholesterol crystallization. Journal of Hepatology 16(Suppl. 1): S66-S67, 1992

Influence of ursodeoxycholic acid udca treatment on the formation of cholesterol monohydrate crystals cmc from cholesterol phospholipid vesicles in human gallbladder bile. Gastroenterology 100(5 Part 2): A749, 1991

Distribution of cholesterol between vesicles and micelles in human gallbladder bile influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid. Hepatology 13(1): 104-110, 1991

Prolonged nucleation time nt and delayed growth of cholesterol crystals in human gallbladder bile by ursodeoxycholic acid udca treatment. Hepatology 7(5): 1139, 1987

Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. Journal of Hepatology 8(1): 1-6, 1989

A study on the size of molecular aggregates formed by bile acid in human gallbladder bile: with special reference to a comparison of bile treated with chenodeoxycholic acid and with ursodeoxycholic acid. Nihon Shokakibyo Gakkai Zasshi 84(6): 1289-1294, 1987

Prolonged cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones under treatment with low dose ursodeoxycholic acid. Gastroenterology 92(5 Part 2): 1742, 1987

CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts. Journal of Cellular Biochemistry 117(9): 2118-2127, 2017

A study on size of molecular aggregates formed by bile acid in human gallbladder bile with special reference to comparison of bile with chenodeoxycholic acid treatment and bile with ursodeoxycholic acid treatment. Japanese Journal of Gastroenterology 84(6): 1289-1294, 1987

A study on size of molecular aggregates formed by bile acid in human gallbladder bile with special reference to comparison of chenodeoxycholic acid rich bile and ursodeoxycholic acid rich bile. Hirosaki Medical Journal 39(3): 414-426, 1987

Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts. Polski Tygodnik Lekarski 38(7): 221-224, 1983

Effect of ursodeoxycholic acid on lithogenic factors in gallbladder bile of patients with cholesterol stones. Gastroenterology 112(4 Suppl. ): A518, 1997